Ionescu DF, Shelton RC, Baer L, Meade KH, Swee MB, Fava M. Papakostas GI: Ziprasidone Augmentation for Anxious Depression. Int Clin Psychoparmacol. (In Press)
Thurm A, Tierney E, Farmer C, Albert P, Joseph L, Swedo S, Bianconi S, Bukelis I, Wheeler C, Sarphare G, Lanham D, Wassif CA, Porter FD. Development, Behavior, and Biomarker Characterization of Smith-Lemli-Opitz Syndrome: An Update. J Neurodev Disord (in press).
Bhambhvani HP, Simmons M, Haroutunian V, and Meador-Woodruff JH. (2016). Decreased Expression of Cortactin in Schizophrenia Brain. NeuroReport. 10;27(3):145-50.
Mueller TM, Remedies CE, Haroutunian V, and Meador-Woodruff JH:  Abnormal Subcellular Localization of GABAA Receptor Subunits in Schizophrenia Brain.  Translational Psychiatry. 5: e612, 2015.  doi:10.1038/tp.2015.102.
Scott MR, Rubio MD, Haroutunian V, and Meador-Woodruff JH: Protein Expression of Proteasome Subunits in Elderly Patients with Schizophrenia. Neuropsychopharmacology. 41: 896-905, 2016.
Dean B, Gibbons AS, Boer S, Uezato A, Meador-Woodruff JH, Scarr E, and McCullumsmith RE:  Changes in Cortical N-Methyl-D-Aspartate Receptors and Postsynaptic Density Protein 95 in Schizophrenia, Mood Disorders and Suicide. Australian and New Zealand Journal of Psychiatry50: 275-283, 2016.
Hammond JC, Lahti AC, Kraguljac NV. Rapid clozapine titration in an acutely agitated patient with schizoaffective disorder: a case report. Journal of Clinical Psychopharmacology. In press
Money KM, Olah Z, Korade Z, Garbett KA, Shelton RC.  An altered peripheral IL6 response in major depressive disorder. Neurobiology of Disease (in press).

Singh JB, Fedgchin M, Daly EJ, De Boer P, Cooper K, Lim P, Pinter C, Murrough JW, Sanacora G, Shelton RC, Kurian B, Winokur A, Fava M, Manji H, Drevets WC, Nueten LV. A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in adult patients with treatment-resistant depression. Am J Psychiatry (in press).
Shelton RC, Pencina MJ, Barrentine LW, Ruiz JA, Fava M, Zajecka JM, Papakostas GI. Association of obesity and inflammatory marker levels on treatment outcome from a double-blind, randomized study of adjunctive l-methylfolate calcium (Deplin) in MDD Patients who are inadequate responders to SSRIs. J Clin Psychiatry 76:1635–1641, 2015